VITAL
Vital Chemtech Limited
Specialty chemicals manufacturer with Vital Synthesis subsidiary
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
vitalgroup.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Vital Chemtech is a chemicals company based in Ahmedabad, Gujarat, run by Chairman and Managing Director Vipul Bhatt, and it reports one business segment.
Company snapshot
64thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Cash flow from operations is higher than reported profit — earnings quality looks solid.
- ✗Revenue fell 6% in the latest year — top line is under pressure.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 | Jun 2026 |
|---|---|---|
| Sales | 35 Cr | 51 Cr |
| Operating expenses (approx.) | 31 Cr | 45 Cr |
| EBITDA | 4 Cr | 6 Cr |
| OPM % | 11.3% | 11.9% |
| Other income | 0.24 Cr | 0.13 Cr |
| Interest | 1 Cr | 1 Cr |
| Depreciation | 2 Cr | 2 Cr |
| Profit before tax | 0.96 Cr | 3 Cr |
| Tax % | 12.4% | 24.6% |
| Net profit | 0.84 Cr | 3 Cr |
| EPS (₹) | ₹0.36 | ₹1.08 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 134 Cr | 126 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 123 Cr | 116 Cr | Sign in free for the trailing twelve months |
| EBITDA | 11 Cr | 10 Cr | Sign in free for the trailing twelve months |
| OPM % | 8.4% | 7.9% | Sign in free for the trailing twelve months |
| Other income | 2 Cr | 1 Cr | Sign in free for the trailing twelve months |
| Interest | 2 Cr | 3 Cr | Sign in free for the trailing twelve months |
| Depreciation | 5 Cr | 6 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 6 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Tax % | 34.7% | 50.8% | Sign in free for the trailing twelve months |
| Net profit | 4 Cr | 1 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹1.69 | ₹0.44 | Sign in free for the trailing twelve months |
| Dividend payout % | 7.8% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 24 Cr | 24 Cr |
| Reserves | 68 Cr | 75 Cr |
| Borrowings | — | 62 Cr |
| Other liabilities | 89 Cr | 57 Cr |
| Total liabilities | 182 Cr | 219 Cr |
| Fixed assets (net) | 84 Cr | 58 Cr |
| CWIP | — | 43 Cr |
| Investments | 20 Cr | 13 Cr |
| Inventories | 14 Cr | 32 Cr |
| Trade receivables | 47 Cr | 40 Cr |
| Cash & bank | 0.79 Cr | 0.88 Cr |
| Other assets | 16 Cr | 32 Cr |
| Total assets | 182 Cr | 219 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | 6 Cr | 5 Cr |
| Cash from investing | -30 Cr | -5 Cr |
| Cash from financing | 25 Cr | 0.58 Cr |
| Net cash flow | 0.33 Cr | 0.07 Cr |
| Free cash flow (OCF − Capex) | -40 Cr | -19 Cr |
Ratios
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 9.1% | 3.2% |
| ROE % | 4.4% | 1.0% |
| Debtor days | 128 | 115 |
| Inventory days | 46 | 111 |
| Days payable | 119 | 173 |
| Cash conversion cycle | 55 | 54 |
| OCF / EBITDA % | 54.6% | 49.0% |
| Debt / equity | — | 0.62 |
| Current ratio | 1.56 | 1.20 |
| Net debt / EBITDA | -0.07 | 6.08 |